The Role of Somatic Mutations on the Immune Response of the Tumor Microenvironment in Prostate Cancer
Immunotherapy has improved patient survival in many types of cancer, but for prostate cancer, initial results with immunotherapy have been disappointing. Prostate cancer is considered an immunologically excluded or cold tumor, unable to generate an effective T-cell response against cancer cells. How...
Main Authors: | Camila Morais Melo, Thiago Vidotto, Luiz Paulo Chaves, William Lautert-Dutra, Rodolfo Borges dos Reis, Jeremy Andrew Squire |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/17/9550 |
Similar Items
-
Epithelial–Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics
by: Luiz Paulo Chaves, et al.
Published: (2021-11-01) -
Role of Oncogenic Pathways on the Cancer Immunosuppressive Microenvironment and Its Clinical Implications in Hepatocellular Carcinoma
by: Naoshi Nishida
Published: (2021-07-01) -
NK Cell Dysfunction and Checkpoint Immunotherapy
by: Jiacheng Bi, et al.
Published: (2019-08-01) -
TRIM31: A molecule with a dual role in cancer
by: Yafei Guo, et al.
Published: (2022-12-01) -
Immunotherapy of targeting MDSCs in tumor microenvironment
by: Hongshu Sui, et al.
Published: (2022-09-01)